Table 2.
Characteristics of study participants who had a coronavirus infection, depending on the severity of the disease.
| Variable | COVID-19 Mild n = 42 (41.2%) |
COVID-19 Moderate and Severe, n = 60 (58.8%) | p |
|---|---|---|---|
| Age, years Me (Q1; Q3) |
41.0 (34.0; 52.0) | 43.0 (32.5; 52.0) | 0.656 |
| Female, (n.%) | 21 (50.0) | 41 (68.3) | 0.062 |
| Male, (n.%) | 21 (50.0) | 19 (31.7) | |
| Urban, (n.%) | 31 (73.81) | 41 (68.3) | 0.550 |
| Rural, (n.%) | 11 (26.19) | 19 (31.7) | |
| Smoking, (n.%) | 9 (21.4) | 4 (6.7) | 0.028 |
| BMI, кг/м2 Me(Q1; Q3) |
27.15 (23.54; 30.34) | 27.66 (24.26; 29.74) | 0.980 |
| Co, mg/g Me (Q1; Q3) |
0.011 (0.006; 0.036) | 0.015 (0.006; 0.043) | 0.420 |
| Cr, mg/g Me (Q1; Q3) |
0.865 (0.528; 0.891) | 0.859 (0.742; 0.908) | 0.395 |
| Cu, mg/g Me (Q1; Q3) |
6.739 (5.657; 8.444) | 8.210 (6.327; 9.830) | 0.024 |
| Fe, mg/g Me (Q1; Q3) |
16.253 (12.550; 21.438) | 15.815 (12.383; 26.202) | 0.736 |
| I, mg/g Me (Q1; Q3) |
0.235 (0.162; 0.346) | 0.203 (0.140; 0.313) | 0.428 |
| Mn, mg/g Me (Q1; Q3) |
0.240 (0.170; 0.329) | 0.267(0.172; 0.543) | 0.651 |
| Se, mg/g Me (Q1; Q3) |
0.497 (0.440; 0.576) | 0.497 (0.392; 0.549) | 0.357 |
| Zn, mg/g Me (Q1; Q3) |
182.654 (154.306; 215.895) | 177.761 (147.691; 212.445) | 0.529 |